WebNews

Please enter a web search for web results.

NewsWeb

WMAZ
13wmaz. com > article > news > local > perry > piedmont-open-new-urgent-care-in-perry-heres-where-it-will-be > 93-f4f38f00-f322-49d1-afd3-f7a9b0a5ec79

Piedmont to open new urgent care in Perry. Here's where it will be

49+ min ago  (253+ words) PERRY, Ga. " Piedmont announced on Thursday that a new urgent care will open in Perry. They said that the new urgent care location will expand access to convenient care for families in the community. The urgent care will be at…...

Symbols: nasdaq:safx
cureusinc
cureus. com > articles > 481817-arterial-stiffness-as-a-predictor-of-postoperative-intensive-care-unit-icu-mortality-an-observational-study

Arterial Stiffness as a Predictor of Postoperative Intensive Care Unit (ICU) Mortality: An Observational Study

1+ hour, 57+ min ago  (1372+ words) Panagiota Gatsori " George Intas " Theodoros A. Katsoulas " Eleni Theodosopoulou " Dimitrios Cholevas " Ilias Skopelitis " Pantelis I. Stergiannis Cite this article as: Gatsori P, Intas G, Katsoulas T A, et al. (May 28, 2026) Arterial Stiffness as a Predictor of Postoperative Intensive Care Unit (ICU) Mortality:…...

Telehealth. org
telehealth. org > news > would-a-common-fund-fix-the-u-s-primary-care-access-crisis

JAMA: Primary Care Common Fund Could Fix U. S. Access Crisis

2+ hour, 32+ min ago  (296+ words) " New Webinar: AI in Digital Health: Navigating Compliance & Understanding Policy | Register for Free | Optional CE Available by Mollie R. Cummins, Ph D, RN | May 28, 2026, 05: 50 ET Only four cents of every U. S. healthcare dollar goes to primary care, and more than one-third of…...

Symbols: btc-usd
BIOENGINEER. ORG
bioengineer. org > fusion-positive-rhabdomyosarcoma-oncofusions-share-interactome

Fusion-Positive Rhabdomyosarcoma Oncofusions Share Interactome

4+ hour, 13+ min ago  (886+ words) In a groundbreaking study set to reshape our understanding of fusion-positive rhabdomyosarcoma (RMS), researchers have uncovered a striking commonality among oncofusions driving this aggressive pediatric cancer. The research, spearheaded by Zimmerman, Delaney, Lau, and colleagues, reveals that diverse fusion proteins…...

Symbols: nasdaq:crdf
cureusinc
cureus. com > articles > 494180-acute-myeloid-leukemia-with-philadelphia-chromosome-and-complex-karyotype-a-diagnostic-dilemma

Acute Myeloid Leukemia With Philadelphia Chromosome and Complex Karyotype: A Diagnostic Dilemma

3+ hour, 17+ min ago  (306+ words) Acute myeloid leukemia (AML) is a hematological malignancy driven by the clonal expansion of immature myeloid cells, with cytogenetic findings playing a defining role in both its diagnosis and risk stratification. The Philadelphia chromosome, generated by the t(9; 22)(q34; q11. 2) translocation and…...

Symbols: flag-go
newswise. com
newswise. com > articles > pepromene-bio-announces-oral-presentation-at-eha-2026-highlighting-favorable-safety-and-durable-responses-with-pmb-ct01-baff-r-car-t-cell-therapy-in-b-cell-lymphomas-including-after-prior-cd19-car-t-cell-failure

Pepro Mene Bio Announces Oral Presentation at EHA 2026 Highlighting Favorable Safety and Durable Responses with PMB-CT01 (BAFF-R CAR T-Cell Therapy) in B-cell Lymphomas, Including After Prior CD19 CAR T-Cell Failure | Newswise

4+ hour, 12+ min ago  (162+ words) Newswise " IRVINE, Calif. , May 28, 2026" -- Pepro Mene Bio, Inc. announced today that updated clinical data from its ongoing Phase 1 study evaluating PMB-CT01, an investigational B-cell activating factor receptor (BAFF-R)-targeted CAR T-cell therapy, have been selected for an oral presentation at…...

Symbols: baff-r
@PRNewswire
prnewswire. com > news-releases > pepromene-bio-announces-oral-presentation-at-eha-2026-highlighting-favorable-safety-and-durable-responses-with-pmb-ct01-baff-r-car-t-cell-therapy-in-b-cell-lymphomas-including-after-prior-cd19-car-t-cell-failure-302783614. html

Pepro Mene Bio Announces Oral Presentation at EHA 2026 Highlighting Favorable Safety and Durable Responses with PMB-CT01 (BAFF-R CAR T-Cell Therapy) in B-cell Lymphomas, Including After Prior CD19 CAR T-Cell Failure

5+ hour, 22+ min ago  (172+ words) May 28, 2026, 07: 00 ET IRVINE, Calif. , May 28, 2026 /PRNewswire/ -- Pepro Mene Bio, Inc. announced today that updated clinical data from its ongoing Phase 1 study evaluating PMB-CT01, an investigational B-cell activating factor receptor (BAFF-R)-targeted CAR T-cell therapy, have been selected for an oral…...

Symbols: baff-r,btc-usd
The Sydney Morning Herald
smh. com. au > national > victoria > patients-are-waiting-1460-days-for-routine-appointments-authorities-think-ai-can-fix-it-20260528-p601ip. html

Patients are waiting 1460 days for routine appointments. Authorities think AI can fix it

49+ min ago  (861+ words) May 28, 2026 " 7: 30pm Victorians are waiting up to four years to access specialist care in the state's public hospitals, triggering a state government overhaul that will create regional waitlists and use AI to flag urgent cases. Under the changes, which have been…...

Symbols: lloy.l,shel.l,btc-usd,0uy9.l,0qui.l,0w8R.0
i NFOnews. ca
infonews. ca > news > 7657961 > exhausting-and-rewarding-entrepreneur-opens-holistic-salt-cave-in-lake-country

'Exhausting and rewarding': Entrepreneur opens holistic salt cave in Lake Country

5+ hour, 22+ min ago  (631+ words) An ambitious entrepreneur with a passion for wellness has opened a studio in Lake Country that features a cave full of 7, 000 kilograms of Himalayan rock salt imported from Pakistan. Kelowna resident Rhonda Smith worked seven days a week for many…...

Symbols: nasdaq:vmd
Irish Medical Times
imt. ie > clinical > managing-relapsed-aml-the-role-of-flt3-inhibitors-in-modern-treatment-pathways-28-05-2026

Managing Relapsed AML: The role of FLT3 inhibitors in modern treatment pathways

6+ hour, 40+ min ago  (386+ words) By Editorial Staff 28th May 2026 As evidence continues to evolve, optimising sequencing, duration, MRD-guided use, and combination approaches will be important areas of focus to improve patient outcomes Biology of relapse in FLT3-mutated AML FLT3 mutations (most commonly internal tandem duplications (FLT3-ITD))…...

Symbols: six:ro